{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:02:15Z","timestamp":1773270135970,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00520-026-10378-7","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:52:50Z","timestamp":1770270770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic associations of LXN polymorphisms with toxicities of platinum-based concurrent chemoradiotherapy of nasopharyngeal carcinoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Youhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiancheng","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiachun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"10192","key":"10378_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"Y-P Chen","year":"2019","unstructured":"Chen Y-P, Chan AT, Le Q-T, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. Lancet 394(10192):64\u201380","journal-title":"Lancet"},{"issue":"11","key":"10378_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","volume":"16","author":"JD Cramer","year":"2019","unstructured":"Cramer JD, Burtness B, Le QT, Ferris RL (2019) The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol 16(11):669\u2013683","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10378_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","volume":"13","author":"L Chen","year":"2012","unstructured":"Chen L, Hu C-S, Chen X-Z, Hu G-Q, Cheng Z-B, Sun Y et al (2012) Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol 13(2):163\u2013171","journal-title":"Lancet Oncol"},{"issue":"11","key":"10378_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","volume":"17","author":"Y Sun","year":"2016","unstructured":"Sun Y, Li W-F, Chen N-Y, Zhang N, Hu G-Q, Xie F-Y et al (2016) Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol 17(11):1509\u20131520","journal-title":"Lancet Oncol"},{"issue":"12","key":"10378_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","volume":"381","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen L, Hu G-Q, Zhang N, Zhu X-D, Yang K-Y et al (2019) Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med 381(12):1124\u20131135","journal-title":"N Engl J Med"},{"key":"10378_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejca.2018.10.020","volume":"110","author":"X-Y Li","year":"2019","unstructured":"Li X-Y, Chen Q-Y, Sun X-S, Liu S-L, Yan J-J, Guo S-S et al (2019) Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma. Eur J Cancer 110:24\u201331","journal-title":"Eur J Cancer"},{"key":"10378_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102883","author":"Y Wu","year":"2025","unstructured":"Wu Y, Shi W, Li C, Liu X, Jiang Y, Qiu Y et al (2025) Managing strategies of chemotherapy and radiotherapy-induced oral mucositis. Cancer Treat Rev. https:\/\/doi.org\/10.1016\/j.ctrv.2025.102883","journal-title":"Cancer Treat Rev"},{"key":"10378_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01715-7","volume":"39","author":"C Pulito","year":"2020","unstructured":"Pulito C, Cristaudo A, Porta CL, Zapperi S, Blandino G, Morrone A et al (2020) Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res 39:1\u201315","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"10378_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biom14050560","volume":"14","author":"AI Mohammed","year":"2024","unstructured":"Mohammed AI, Fedoruk L, Fisher N, Liu AX, Khanna S, Naylor K et al (2024) Systemic anti-inflammatory agents in the prevention of chemoradiation-induced mucositis: a review of randomised controlled trials. Biomolecules 14(5):560","journal-title":"Biomolecules"},{"issue":"23","key":"10378_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235705","volume":"15","author":"AJ Nicol","year":"2023","unstructured":"Nicol AJ, Ching JC, Tam VC, Liu KC, Leung VW, Cai J et al (2023) Predictive factors for chemoradiation-induced oral mucositis and dysphagia in head and neck cancer: a scoping review. Cancers 15(23):5705","journal-title":"Cancers"},{"issue":"5","key":"10378_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050949","volume":"16","author":"R Cavalieri","year":"2024","unstructured":"Cavalieri R, de Oliveira HF, de Louvain Souza T, Kanashiro MM (2024) Single nucleotide polymorphisms as biomarker predictors of oral mucositis severity in head and neck cancer patients submitted to combined radiation therapy and chemotherapy: a systematic review. Cancers 16(5):949","journal-title":"Cancers"},{"key":"10378_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02390-0","volume":"18","author":"D-W Yang","year":"2020","unstructured":"Yang D-W, Wang T-M, Zhang J-B, Li X-Z, He Y-Q, Xiao R et al (2020) Genome-wide association study identifies genetic susceptibility loci and pathways of radiation-induced acute oral mucositis. J Transl Med 18:1\u201312","journal-title":"J Transl Med"},{"key":"10378_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6707821","author":"Z Guo","year":"2022","unstructured":"Guo Z, Wang Y-J, He B-S, Zhou J (2022) Linc00312 single nucleotide polymorphism as biomarker for chemoradiotherapy induced hematotoxicity in nasopharyngeal carcinoma patients. Dis Markers. https:\/\/doi.org\/10.1155\/2022\/6707821","journal-title":"Dis Markers"},{"issue":"1","key":"10378_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-025-06278-7","volume":"25","author":"M Dai","year":"2025","unstructured":"Dai M, Dai X, Liang Y, Li X, Huang H, Zhao W (2025) Keratinocyte necroptosis promotes the progression of radiation-induced oral mucositis. BMC Oral Health 25(1):941","journal-title":"BMC Oral Health"},{"issue":"9","key":"10378_CR15","volume":"32","author":"K Yoshida","year":"2024","unstructured":"Yoshida K, Kiyomi A, Kurokawa A, Hoshino N, Saito C, Koga M et al (2024) Association between salivary inflammatory mediators and oral mucositis in patients with cancer undergoing chemotherapy. Support Care Cancer 32(9):625","journal-title":"Support Care Cancer"},{"issue":"3","key":"10378_CR16","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3892\/or.2014.2966","volume":"31","author":"Q-F Ni","year":"2014","unstructured":"Ni Q-F, Tian Y, Kong L-L, Lu Y-T, Ding W-Z, Kong L-B (2014) Latexin exhibits tumor suppressor potential in hepatocellular carcinoma. Oncol Rep 31(3):1364\u20131372","journal-title":"Oncol Rep"},{"issue":"1","key":"10378_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3892\/or.2015.4353","volume":"35","author":"Z Xue","year":"2016","unstructured":"Xue Z, Zhou Y, Wang C, Zheng J, Zhang P, Zhou L et al (2016) Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. Oncol Rep 35(1):50\u201358","journal-title":"Oncol Rep"},{"issue":"1","key":"10378_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01227-7","volume":"8","author":"Y Li","year":"2022","unstructured":"Li Y, Tan Y, Li X, Chen X, Wang L, Zhang L et al (2022) Loss of LXN promotes macrophage M2 polarization and PD-L2 expression contributing cancer immune-escape in mice. Cell Death Discov 8(1):440","journal-title":"Cell Death Discov"},{"issue":"10","key":"10378_CR19","doi-asserted-by":"publisher","first-page":"e1493","DOI":"10.1038\/cddis.2014.443","volume":"5","author":"Y You","year":"2014","unstructured":"You Y, Wen R, Pathak R, Li A, Li W, St Clair D et al (2014) Latexin sensitizes leukemogenic cells to gamma-irradiation-induced cell-cycle arrest and cell death through Rps3 pathway. Cell Death Dis 5(10):e1493-e","journal-title":"Cell Death Dis"},{"issue":"1","key":"10378_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66789-x","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, Huang B, Yang H, Kan S, Yao Y, Liu X et al (2020) Latexin deficiency in mice up-regulates inflammation and aggravates colitis through HECTD1\/Rps3\/NF-\u03baB pathway. Sci Rep 10(1):9868","journal-title":"Sci Rep"},{"issue":"2","key":"10378_CR21","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.1016\/j.ijrobp.2017.06.577","volume":"99","author":"S Nanda","year":"2017","unstructured":"Nanda S, Gandhi A, Rastogi M, Bhatt M, Sahni K, Mishra S et al (2017) Evaluation of XRCC-1 gene polymorphism as a biomarker in head and neck cancer patients undergoing chemoradiation therapy. Int J Radiat Oncol Biol Phys 99(2):S236. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.06.577","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10378_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.radonc.2011.05.062","volume":"99","author":"N Pratesi","year":"2011","unstructured":"Pratesi N, Mangoni M, Mancini I, Paiar F, Simi L, Livi L et al (2011) Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiother Oncol 99(3):356\u201361","journal-title":"Radiother Oncol"},{"issue":"4","key":"10378_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.ijrobp.2008.08.073","volume":"73","author":"J Werbrouck","year":"2009","unstructured":"Werbrouck J, De Ruyck K, Duprez F, Veldeman L, Claes K, Van Eijkeren M et al (2009) Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys 73(4):1187\u201395","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10378_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.oraloncology.2017.02.003","volume":"67","author":"D Borchiellini","year":"2017","unstructured":"Borchiellini D, Etienne-Grimaldi M, Bensadoun R, Benezery K, Dassonville O, Poissonnet G et al (2017) Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer. Oral Oncol 67:70\u20136","journal-title":"Oral Oncol"},{"issue":"4","key":"10378_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1158\/1541-7786.MCR-16-0392","volume":"15","author":"M Zhang","year":"2017","unstructured":"Zhang M, Osisami M, Dai J, Keller JM, Escara-Wilke J, Mizokami A et al (2017) Bone microenvironment changes in latexin expression promote chemoresistance. Mol Cancer Res 15(4):457\u201366","journal-title":"Mol Cancer Res"},{"key":"10378_CR26","first-page":"1","volume":"12","author":"H Zhang","year":"2014","unstructured":"Zhang H, Ren Y, Pang D, Liu C (2014) Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer. World J Surg Oncol 12:1\u20137","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10378_CR27","first-page":"1","volume":"16","author":"Y Liang","year":"2025","unstructured":"Liang Y, Wang X, Shi X, Fei X (2025) Risk factors and prediction models for severe radiation-induced oral mucositis in patients with nasopharyngeal carcinoma undergoing chemoradiotherapy. Discov Oncol 16(1):1\u201310","journal-title":"Discov Oncol"},{"key":"10378_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.oraloncology.2018.10.006","volume":"86","author":"E Orlandi","year":"2018","unstructured":"Orlandi E, Iacovelli NA, Rancati T, Cicchetti A, Bossi P, Pignoli E et al (2018) Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients. Oral Oncol 86:266\u201372","journal-title":"Oral Oncol"},{"issue":"12","key":"10378_CR29","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.3324\/haematol.2022.282028","volume":"108","author":"C Zhang","year":"2023","unstructured":"Zhang C, Cui X, Liu Y, Wang F, Signer R, Nattamai K et al (2023) Latexin deletion protects against radiation-induced hematopoietic damages via selective activation of Bcl-2 prosurvival pathway. Haematologica 108(12):3464","journal-title":"Haematologica"},{"issue":"4","key":"10378_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.oraloncology.2007.05.008","volume":"44","author":"P Yanatatsaneejit","year":"2008","unstructured":"Yanatatsaneejit P, Chalermchai T, Kerekhanjanarong V, Shotelersuk K, Supiyaphun P, Mutirangura A et al (2008) Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma. Oral Oncol 44(4):400\u20136","journal-title":"Oral Oncol"},{"issue":"1","key":"10378_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00459-0","volume":"19","author":"Y Guo","year":"2024","unstructured":"Guo Y, Chai B, Zhang H, Chai X, Chen Y, Xu J et al (2024) RARRES1 inhibits hepatocellular carcinoma progression and increases its sensitivity to lenvatinib through interaction with SPINK2. Biol Direct 19(1):15","journal-title":"Biol Direct"},{"issue":"4","key":"10378_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.6","volume":"2","author":"E Oldridge","year":"2013","unstructured":"Oldridge E, Walker H, Stower M, Simms M, Mann V, Collins A et al (2013) Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN. Oncogenesis 2(4):e45-e","journal-title":"Oncogenesis"},{"issue":"12","key":"10378_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208756","volume":"13","author":"S Maimouni","year":"2018","unstructured":"Maimouni S, Issa N, Cheng S, Ouaari C, Cheema A, Kumar D et al (2018) Tumor suppressor RARRES1-a novel regulator of fatty acid metabolism in epithelial cells. PLoS One 13(12):e0208756","journal-title":"PLoS One"},{"key":"10378_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s13105-015-0445-5","volume":"71","author":"Y Sun","year":"2015","unstructured":"Sun Y, Fu A, Xu W, Chao J-R, Moshiach S, Morris SW (2015) Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3. J Physiol Biochem 71:807\u201321","journal-title":"J Physiol Biochem"},{"issue":"8","key":"10378_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000204","volume":"7","author":"Z Tang","year":"2023","unstructured":"Tang Z, Yang Y, Chen W, Liang T (2023) Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR\/AKT and Wnt\/\u03b2-catenin signaling. Hepatol Commun 7(8):e0204","journal-title":"Hepatol Commun"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10378-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:44:36Z","timestamp":1773215076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10378-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10378"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10378-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Independent Ethical Committee of the Institute of Clinical Pharmacology, Central South University (Approval No. CTXY-140007\u20132). All procedures involving human participants were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. The manuscript does not contain any identifiable personal data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}